UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 24,
Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Citius Pharmaceuticals Charts.
Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Citius Pharmaceuticals Charts.

Citius Pharmaceuticals, Inc. News

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering
Wednesday 1 May 2024 (1 day ago) • PR Newswire (US)
Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
Friday 26 April 2024 (6 days ago) • PR Newswire (US)
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Thursday 11 April 2024 (3 weeks ago) • PR Newswire (US)
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
Thursday 4 April 2024 (4 weeks ago) • PR Newswire (US)
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Monday 18 March 2024 (1 month ago) • PR Newswire (US)
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Friday 8 March 2024 (2 months ago) • PR Newswire (US)
Form EFFECT - Notice of Effectiveness
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)
Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration
Monday 26 February 2024 (2 months ago) • PR Newswire (US)
Form S-3 - Registration statement under Securities Act of 1933
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)
Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences
Saturday 24 February 2024 (2 months ago) • PR Newswire (US)
Form 8-K - Current report
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

More Citius Pharmaceuticals, Inc. News Articles